Cargando…

Insights in a restricted temporary pacemaker strategy in a lean transcatheter aortic valve implantation program

OBJECTIVES: To study the safety and feasibility of a restrictive temporary‐RV‐pacemaker use and to evaluate the need for temporary pacemaker insertion for failed left ventricular (LV) pacing ability (no ventricular capture) or occurrence of high‐degree AV‐blocks mandating continuous pacing. BACKGROU...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hokken, Thijmen W., de Ronde, Marjo, Wolff, Quinten, Schermers, Thom, Ooms, Joris F., van Wiechen, Maarten P., Kardys, Isabella, Daemen, Joost, de Jaegere, Peter P., Van Mieghem, Nicolas M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Valvular and Structural Heart Diseases
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9539864/ https://www.ncbi.nlm.nih.gov/pubmed/34837467 http://dx.doi.org/10.1002/ccd.30026

Ejemplares similares

Vascular complications with a plug‐based vascular closure device after transcatheter aortic valve replacement: Predictors and bail‐outs
por: van Wiechen, Maarten P., et al.
Publicado: (2021)

Dedicated plug based closure for large bore access –The MARVEL prospective registry
por: Kroon, Herbert G., et al.
Publicado: (2020)

TCT-422 The Impact of the COVID-19 Pandemic on the Clinical Status of Patients Referred for TAVR
por: Ooms, Joris, et al.
Publicado: (2021)

Changing haemodynamic status of patients referred for transcatheter aortic valve intervention during the COVID-19 pandemic
por: Ooms, Joris F., et al.
Publicado: (2023)

Publisher Correction to: Changing haemodynamic status of patients referred for transcatheter aortic valve intervention during the COVID-19 pandemic
por: Ooms, Joris F., et al.
Publicado: (2023)

Comparison of the Sapien 3 versus the ACURATE neo valve system: A propensity score analysis
por: Kooistra, Nynke H., et al.
Publicado: (2020)

Final 3‐year clinical outcomes following transcatheter aortic valve implantation with a supra‐annular self‐expanding repositionable valve in a real‐world setting: Results from the multicenter FORWARD study
por: Van Mieghem, Nicolas M., et al.
Publicado: (2021)

Transcatheter Repair and Replacement Technologies for Mitral Regurgitation: a European Perspective
por: Ooms, Joris F., et al.
Publicado: (2021)

Clinical outcomes of the Lotus Valve in patients with bicuspid aortic valve stenosis: An analysis from the RESPOND study
por: Blackman, Daniel J., et al.
Publicado: (2019)

Conceptual model for early health technology assessment of current and novel heart valve interventions
por: Huygens, Simone A, et al.
Publicado: (2016)

Modifiable risk factors for permanent pacemaker after transcatheter aortic valve implantation: CONDUCT registry
por: Rudolph, Tanja, et al.
Publicado: (2023)

The Impact of the COVID-19 Pandemic on the Clinical Status of Patients Referred for TAVR
por: Ooms, Joris F., et al.
Publicado: (2022)

The impact of frailty on adverse outcomes after transcatheter aortic valve replacement in older adults: A retrospective cohort study
por: Dautzenberg, Lauren, et al.
Publicado: (2022)

Large-bore Vascular Closure: New Devices and Techniques
por: van Wiechen, Maarten P, et al.
Publicado: (2019)

Validation of a Three-Dimensional Computed Tomography Reconstruction Tool for Aortic Valve Calcium Quantification
por: Hokken, Thijmen W., et al.
Publicado: (2022)

Discordant severity criteria in patients with moderate aortic stenosis: prognostic implications
por: Pio, Stephan M, et al.
Publicado: (2021)

Clinical outcomes after TAVR with heparin or bivalirudin as periprocedural anticoagulation in patients with and without peripheral arterial disease: Results from the BRAVO‐3 randomized trial
por: Zilberszac, Robert, et al.
Publicado: (2019)

Sex-specific aortic valve calcifications in patients undergoing transcatheter aortic valve implantation
por: Hokken, Thijmen W, et al.
Publicado: (2023)

Single center TAVR experience with a focus on the prevention and management of catastrophic complications
por: Kapadia, Samir R, et al.
Publicado: (2014)

Supra‐annular structure assessment for self‐expanding transcatheter heart valve size selection in patients with bicuspid aortic valve
por: Liu, Xianbao, et al.
Publicado: (2018)

A comparison of valve‐in‐valve transcatheter aortic valve replacement in failed stentless versus stented surgical bioprosthetic aortic valves
por: Choi, Charles H., et al.
Publicado: (2018)

One‐year clinical outcome with a novel self‐expanding transcatheter heart valve
por: Pellegrini, Costanza, et al.
Publicado: (2019)

Clinical risk model for predicting 1‐year mortality after transcatheter aortic valve replacement
por: Yamamoto, Masanori, et al.
Publicado: (2020)

Tricuspid regurgitation after transcatheter mitral valve repair: Clinical course and impact on outcome
por: Meijerink, Frank, et al.
Publicado: (2021)

Hemodynamic comparison of transcatheter aortic valve replacement with the SAPIEN 3 Ultra versus SAPIEN 3: The HomoSAPIEN registry
por: Moriyama, Noriaki, et al.
Publicado: (2020)

TAVR and stroke: A common evolution
por: Tarantini, Giuseppe, et al.
Publicado: (2022)

Comparative differences of mitral valve‐in‐valve implantation: A new mitral bioprosthesis versus current mosaic and epic valves
por: Wang, Dee Dee, et al.
Publicado: (2021)

Uninterrupted vitamin K antagonists in patients undergoing transcatheter aortic valve implantation: A promising strategy still looking for the right patient
por: Tarantini, Giuseppe, et al.
Publicado: (2022)

Novel oral anticoagulants versus vitamin K antagonists in transcatheter aortic valve replacement treated patients—Patients' vulnerability still matters
por: Tarantini, Giuseppe, et al.
Publicado: (2022)

Doing procedures for patients rather than to patients
por: Malik, Shahbaz A., et al.
Publicado: (2022)

Transcatheter mitral valve repair in a high‐surgical risk patient with severe degenerative mitral regurgitation using the novel DragonFly™ Transcatheter Repair device—First in man implantation in China
por: Liu, Xianbao, et al.
Publicado: (2021)

Volume of contrast to creatinine clearance ratio predicts early mortality and AKI after TAVI
por: Venturi, Gabriele, et al.
Publicado: (2022)

Transcatheter aortic valve implantation with the novel‐generation Navitor device: Procedural and early outcomes
por: Corcione, Nicola, et al.
Publicado: (2022)

Cardiovascular outcomes in patients with left atrial enlargement undergoing transcatheter aortic valve implantation
por: Asami, Masahiko, et al.
Publicado: (2022)

Percutaneous closure of patent foramen ovale for treatment of hypoxemia: A case series and physiology review
por: Robl, Jared, et al.
Publicado: (2022)

Transcatheter aortic valve replacement for native and prosthetic aortic regurgitation: Two birds with one stone
por: Tarantini, Giuseppe, et al.
Publicado: (2022)

Mass to voltage ratio index predicts mortality following TAVI
por: Porat, Alon, et al.
Publicado: (2022)

Temporal trends in transcatheter aortic valve replacement use and outcomes by race, ethnicity, and sex
por: Yong, Celina M., et al.
Publicado: (2022)

Endocarditis following transcatheter or surgical aortic valve replacement: What's the difference?
por: Goldsweig, Andrew M., et al.
Publicado: (2022)

Temporal changes and clinical significance of peridevice leak following left atrial appendage occlusion with Amplatzer devices
por: Korsholm, Kasper, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7nhjbfkr8g40jsqamhr25t3rip